FindTrial
Sign In

Effect of EC50 of different temperature ropivacaine combined with dexmedetomidine in ultrasound-guided axillary brachial plexus block

Effect of EC50 of different temperature ropivacaine combined with dexmedetomidine in ultrasound-guided axillary brachial plexus block

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016721
Enrollment
Unknown
Registered
2018-06-19
Start date
2018-06-25
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand injury

Interventions

A group:4 degree C ropivacaine+1ug/kg dexmedetomidine
B group:22 degree C ropivacaine+1ug/kg dexmedetomidine
C group:37 degree C ropivacaine+1ug/kg dexmedetomidine

Sponsors

Shunde Hospital of Southern Medical University (the First People's Hospital of Shunde)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged 18-65 years, with type 2 diabetes, ASA I-II, patients with hand injury and all patients had a clear awareness and fluent language in preoperative

Exclusion criteria

Exclusion criteria: Refuse to participate; Serious hepatic or renal dysfunction; Cardiovascular disease or dysfunction of blood coagulation; Related drug allergie

Design outcomes

Primary

MeasureTime frame
Sensory block time;Motor block time;Adverse reactions;—

Secondary

MeasureTime frame
Calm score;Concentration of ropivacaine;—

Countries

China

Contacts

Public ContactZhang Zhongqi

Shunde Hospital of Southern Medical University (the First People's Hospital of Shunde)

jxzzq11@139.com+86 13798682324

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026